XML 67 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUBSEQUENT EVENTS (Details Narrative)
1 Months Ended 12 Months Ended
Sep. 04, 2018
USD ($)
$ / shares
shares
Sep. 30, 2018
Jul. 16, 2018
Apr. 19, 2018
CAD ($)
Apr. 18, 2018
EUR (€)
Mar. 16, 2018
USD ($)
Feb. 20, 2018
USD ($)
Integer
shares
Dec. 31, 2017
USD ($)
$ / shares
Jun. 30, 2018
USD ($)
$ / shares
Mar. 14, 2018
USD ($)
Nov. 15, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
$ / shares
Line of credit facility, borrowed amount               $ 3,110,714 $ 3,078,442      
Outstanding principal balance                 2,109,281      
Accrued interest                 269,930      
Convertible notes payable, principal amount                 $ 1,311,286      
Common stock, par value | $ / shares               $ 0.001 $ 0.001     $ 0.001
Securities Purchase Agreement [Member] | Warrant [Member]                        
Common stock shares issuable upon conversion of debt/convertible securities | shares             536,000       536,000  
Common stock, par value | $ / shares                     $ 5.00  
Senior Convertible Notes [Member] | Securities Purchase Agreement [Member]                        
Common stock shares issuable upon conversion of debt/convertible securities | shares                     670,000  
Common stock, par value | $ / shares                     $ 0.001  
Institutional investors [Member] | Senior Convertible Note 1 [Member] | Securities Purchase Agreement [Member]                        
Convertible notes payable, principal amount                     $ 3,000,000  
Institutional investors [Member] | Senior Convertible Note 2 [Member] | Securities Purchase Agreement [Member]                        
Convertible notes payable, principal amount                     $ 3,350,000  
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Warrant [Member]                        
Common stock shares issuable upon conversion of debt/convertible securities | shares 357,334                      
Common stock, par value | $ / shares $ 7.50                      
Subsequent Event [Member] | Senior Convertible Notes [Member] | Securities Purchase Agreement [Member]                        
Common stock shares issuable upon conversion of debt/convertible securities | shares 372,223                      
Common stock, par value | $ / shares $ 6.00                      
Purchase price of notes $ 2,000,000                      
Net proceeds 1,845,000                      
Subsequent Event [Member] | Chief Executive Officer [Member]                        
Due to related party           $ 246,010       $ 371,383    
Subsequent Event [Member] | Institutional investors [Member] | Senior Convertible Note 1 [Member] | Securities Purchase Agreement [Member]                        
Convertible notes payable, principal amount 2,233,333                      
Subsequent Event [Member] | Institutional investors [Member] | Senior Convertible Note 2 [Member] | Securities Purchase Agreement [Member]                        
Convertible notes payable, principal amount $ 3,350,000                      
Subsequent Event [Member] | Third Party Loan Agreement [Member]                        
Line of credit facility, borrowed amount           $ 1,845,072            
Line of credit facility, interest rate           4.70%            
Line of credit facility, maturity date           Mar. 16, 2019            
Subsequent Event [Member] | Amendment and Exchange of Agreements [Member] | New senior convertible note [Member]                        
Number of agreements | Integer             2          
Maturity date, description             The New Note shall not be convertible into shares of the Company’s common stock (the “Common Stock”) until April 20, 2018          
Description for the payment of installments             All future cash installment payments under such New Note will be made at a redemption price equal to 112% of the applicable installment amount          
Description for the obligation to deliver predelivery shares             The Company’s existing obligation to initially deliver predelivery shares of its common stock to the holder of such New Note is deferred until April 20, 2018          
Description for the redemption of the note             At any time on or before June 20, 2018, the Company has the right, at its option, to redeem all, or any part, of the amounts then outstanding under such New Note in cash at redemption price equal to 125% of such amounts then outstanding under such New Note          
Senior debt             $ 3,350,000          
Subsequent Event [Member] | Amendment and Exchange of Agreements 1 [Member] | New senior convertible note [Member]                        
Senior debt             2,791,668          
Subsequent Event [Member] | Amendment and Exchange of Agreements 2 [Member] | New senior convertible note [Member]                        
Senior debt             $ 558,332          
Subsequent Event [Member] | Abbydale Management Limited [Member]                        
Description of share exchange agreement   <p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company sold one hundred (100%) percent of the issued share capital of its subsidiary, Amplerissimo Ltd., a limited liability company organized under the laws of Cypress, to the purchaser for a purchase price of €5,000. Amplerissimo had previously transferred one hundred (100%) percent of the capital stock of Sky Pharm SA to the Company.</font></p>                    
Subsequent Event [Member] | Loan Facility [Member]                        
Line of credit facility, interest rate               10.00%        
Outstanding principal balance               $ 3,117,287        
Accrued interest               $ 136,800        
Line of credit facility, interest rate description               <p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The interest rate was restated as of January 1, 2018 to four (4%) percent plus quarterly Libor Payments, plus two (2%) percent default interest on unpaid amounts in addition to the interest rate. The Loan Facility permits prepayment and is due upon the earlier of (i) 75 days following demand of the Lender; or (ii) December 31, 2021, as amended. The Loan Facility is secured by a personal guaranty of Grigorios Siokas which is secured by a pledge of 1,000,000 shares of common stock of the Company owned by Mr. Siokas.</font></p>        
SkyPharm S.A [Member] | Subsequent Event [Member]                        
Payment of financing services | €         € 104,000              
Marathon Global Inc [Member] | Subsequent Event [Member]                        
Description of share exchange agreement     <p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company had transferred one-half of its interest in Marathon to KBB in exchange for five million shares of KBB. Pursuant to the terms of the new SEA, the Company transferred its remaining one-half interest (2.5 million shares) in Marathon to KBB. The Company received an additional five million shares of KBB. Completion of the New SEA by the Company was subject to satisfaction of various conditions precedent all of which have been satisfied. The ten million shares of KBB owned by the Company constitute approximately 7% of the 141,219,108 shares of capital stock of KBB issued and outstanding. The Company does not have the ability to exercise significant influence over KBB.</font></p>                  
Marathon Global Inc [Member] | Subsequent Event [Member] | Distribution and Equity Agreement [Member]                        
Description for the term of agreement       The Agreement is to remain in effect indefinitely unless Marathon fails to provide Market Competitive (as defined) product pricing and Marathon has not become profitable within five (5) years of this Agreement                
Description for the consideration receivable under agreement       Following a thirty (30) day due diligence period, and subject to satisfactory due diligence of the Company, Marathon shall: (a) grant the Company a 33 1/3% equity interest in Marathon as partial consideration for the Company’s distribution services; and (b) make a cash payment of CAD $2,000,000 to the Company, subject to repayment by the Company in Common Shares of the Company if it fails to meet certain performance milestones                
Amount receivable upon satisfactory due diligence       $ 2,000,000                
Description for the additional consideration receivable under agreement       The Company is entitled to receive an additional CAD $2,750,000 upon the Company’s receipt of gross sales of CAD $6,500,000 and an additional CAD $2,750,000 upon receipt of gross sales of CAD $13,000,000. The Company was also given the right to nominate one director to the Marathon Board of Directors                
Marathon Global Inc [Member] | Subsequent Event [Member] | Distribution and Equity Agreement [Member] | Target 2 [Member]                        
Additional consideration receivable upon meeting of target       $ 2,750,000                
Gross sales target for consideration receivable       13,000,000                
Initial payment for consideration receivable       2,000,000                
Marathon Global Inc [Member] | Subsequent Event [Member] | Distribution and Equity Agreement [Member] | Target 1 [Member]                        
Additional consideration receivable upon meeting of target       2,750,000                
Gross sales target for consideration receivable       $ 6,500,000